Literature DB >> 18031286

Protein-tyrosine kinase CAKbeta/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 alpha2 helix and thus forming its dimer.

Takayuki Kohno1, Eiko Matsuda, Hiroko Sasaki, Terukatsu Sasaki.   

Abstract

CAKbeta (cell adhesion kinase beta)/PYK2 (proline-rich tyrosine kinase 2) is the second protein-tyrosine kinase of the FAK (focal adhesion kinase) subfamily. It is different from FAK in that it is activated following an increase in cytoplasmic free Ca2+. In the present study we have investigated how Ca2+ activates CAKbeta/PYK2. Calmodulin-agarose bound CAKbeta/PYK2, but not FAK, in the presence of CaCl2. An alpha-helix (F2-alpha2) present in the FERM (band four-point-one, ezrin, radixin, moesin homology) F2 subdomain of CAKbeta/PYK2 was the binding site of Ca2+/calmodulin; a mutant of this region, L176A/Q177A (LQ/AA) CAKbeta/PYK2, bound to Ca2+/calmodulin much less than the wild-type. CAKbeta/PYK2 is known to be prominently tyrosine phosphorylated when overexpressed from cDNA. The enhanced tyrosine phosphorylation was inhibited by W7, an inhibitor of calmodulin, and by a cell-permeable Ca2+ chelator and was almost defective in the LQ/AA-mutant CAKbeta/PYK2. CAKbeta/PYK2 formed a homodimer on binding of Ca2+/calmodulin, which might then induce a conformational change of the kinase, resulting in transphosphorylation within the dimer. The dimer was formed at a free-Ca2+ concentration of 8-12 muM and was stable at 500 nM Ca2+, but dissociated to a monomer in a Ca2+-free buffer. The dimer formation of CAKbeta/PYK2 FERM domain was partially defective in the LQ/AA-mutant FERM domain and was blocked by W7 and by a synthetic peptide with amino acids 168-188 of CAKbeta/PYK2, but not by a peptide with its LQ/AA-mutant sequence. It is known that the F2-alpha2 helix is found immediately adjacent to a hydrophobic pocket in the FERM F2 lobe, which locks, in the autoinhibited FAK, the C-lobe of the kinase domain. Our results indicate that Ca2+/calmodulin binding to the FERM F2-alpha2 helix of CAKbeta/PYK2 releases its kinase domain from autoinhibition by forming a dimer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18031286     DOI: 10.1042/BJ20070665

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

2.  Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers.

Authors:  Kimberle A Agle; Rebecca A Vongsa; Michael B Dwinell
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

3.  Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.

Authors:  Ssang-Taek Lim; Nichol L G Miller; Ju-Ock Nam; Xiao Lei Chen; Yangmi Lim; David D Schlaepfer
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

4.  Pyk2 cytonuclear localization: mechanisms and regulation by serine dephosphorylation.

Authors:  Camille Faure; Mariana Ramos; Jean-Antoine Girault
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

5.  Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Authors:  Huocong Huang; Robert A Svoboda; Audrey J Lazenby; Jintana Saowapa; Nina Chaika; Ke Ding; Margaret J Wheelock; Keith R Johnson
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

6.  Regulation of the tyrosine kinase Pyk2 by calcium is through production of reactive oxygen species in cytotoxic T lymphocytes.

Authors:  Tara L Lysechko; Samuel M S Cheung; Hanne L Ostergaard
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

Review 7.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

8.  Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.

Authors:  Nathalie Meurice; Lei Wang; Christopher A Lipinski; Zhongbo Yang; Christopher Hulme; Joseph C Loftus
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

9.  Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1.

Authors:  Wei-Zhong Ying; Kristal Aaron; Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

Review 10.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.